Prot# MSLT-II: Multicenter Selective Lymphadenectomy Trial II (MSLT-II): A Phase III Multicenter Randomized trial of Sentinel Lymphadenectomy and Complete Lymph Node Dissection versus Sentinel Lymphadenectomy Alone in Cutaneous Melanoma Patients with Mol